Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lassen

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgeryB I Eriksson, A G G Turpie, M R Lassen, et al.
Thrombosis Research|July 1, 1991
Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplastyL C Borris, J V Sørensen, M R Lassen, et al.
The Journal of Bone and Joint Surgery. British Volume|May 2, 2009
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementB I Eriksson, A K Kakkar, A G G Turpie, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic reviewA Y Y Lee, M Gent, J A Julian, et al.
The Bone & Joint Journal|March 30, 2013
Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 studyW D Fisher, G Agnelli, D J George, et al.
JAMA|January 15, 2020
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical TrialJeffrey I Weitz, Rupert Bauersachs, Bastian Becker, et al.
Haemostasis|March 1, 1993
Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunctionJ V Sørensen, H P Jensen, H B Rahr, et al.
Thrombosis and Haemostasis|October 19, 2013
Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)Bengt I Eriksson, Giancarlo Agnelli, Alexander S Gallus, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1991
Biologic tolerance of two different low molecular weight heparinsH M Christiansen, M R Lassen, L C Borris, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 14, 2014
Sustained release of tissue factor following thrombosis of lower limb traumaJeanine M Walenga, Phoebe C Kaiser, M Margaret Prechel, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgeryB I Eriksson, A G G Turpie, M R Lassen, et al.
Thrombosis Research|July 1, 1991
Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplastyL C Borris, J V Sørensen, M R Lassen, et al.
The Journal of Bone and Joint Surgery. British Volume|May 2, 2009
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementB I Eriksson, A K Kakkar, A G G Turpie, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic reviewA Y Y Lee, M Gent, J A Julian, et al.
The Bone & Joint Journal|March 30, 2013
Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 studyW D Fisher, G Agnelli, D J George, et al.
JAMA|January 15, 2020
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical TrialJeffrey I Weitz, Rupert Bauersachs, Bastian Becker, et al.
Haemostasis|March 1, 1993
Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunctionJ V Sørensen, H P Jensen, H B Rahr, et al.
Thrombosis and Haemostasis|October 19, 2013
Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3)Bengt I Eriksson, Giancarlo Agnelli, Alexander S Gallus, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1991
Biologic tolerance of two different low molecular weight heparinsH M Christiansen, M R Lassen, L C Borris, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 14, 2014
Sustained release of tissue factor following thrombosis of lower limb traumaJeanine M Walenga, Phoebe C Kaiser, M Margaret Prechel, et al.
Pageof 14